Home Meetings Online CME/CE Clinical Resources Amazing Charts

West Annual Conference

Location: Anaheim, CA
Date: March 26-29, 2014

Meeting Overview

Venue:
Anaheim Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

Thank you to the 7,100 Primary Care Clinicians that joined us at Pri-Med West.


See snapshots from Pri-Med West in the slideshow above.


Upcoming meetings near you:

Pri-Med Long Beach | June 4–5
Register now »

Pri-Med Seattle | June 16–17
Register now »

Pri-Med Denver | June 10–11
Register now »


For those who look to you—you can look to us.

Primary care is where good health begins. It is based on your relationship with your patients as you provide and coordinate the care they need, from preventive health to specialty care to inpatient services. The demands and challenges you face every day within your practice are constantly changing, so we’re changing with you.

We’ve taken the feedback of clinicians in your region and across the country to launch an all-new Annual Conference.

Pri‑Med has expanded its partnership with the American College of Physicians (ACP), and in collaboration with the ACP we will be unveiling an entirely new cutting-edge CME curriculum. At Pri-Med West you will also be able to choose from entire track of curriculum developed in collaboration with the David Geffen School of Medicine at UCLA. The CME sessions will include the latest treatments and therapies, such as:

  • Live Demonstration Orthopedic Exam: See It, Do It
  • Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
  • The Overweight Child: Tips for the Primary Care Provider

View the full session schedule»

But that’s not all…

In addition to over 55 new educational sessions, there are many new components of the conference that were created with you in mind.

  • Join us on Thursday night for an Opening Night Reception with complimentary cocktails and hors d’oeuvres
  • New York Times bestselling author John La Puma, MD will sign his book Refuel: A 24-Day Eating Plan to Shed Fat, Boost Testosterone, and Pump Up Strength and Stamina in the Exhibit Hall Booth #821 on Thursday from 9–10am. Complimentary books will be given to the first 100 clinicians!
  • SAFE Opioid Prescribing certification sessions featuring a faculty meet and greet and book signing
  • Two renowned Keynote Speakers including Michael Dansinger, MD, , a weight loss and nutrition consultant for NBC’s “The Biggest Loser” and Story Musgrave, MD, former NASA astronaut and part-time trauma surgeon.

Keynote speaker sneak peeks »

Earn up to 27 AMA PRA Category 1 Credits™ or 27 AANP contact hours of continuing education by attending all 4 days.

Register Today

Register for Pri‑Med West by: Your price**
December 5 $30
January 22 $40
March 5 $55
March 23 $75
Onsite at Pri‑Med West $100

*Primary Care Updates tracks are sponsored by pmiCME and are produced independently of and are not affiliated with the American College of Physicians. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

**Price represents online registration; registration by phone is an additional $10.

Good Health Begins Here

Comprehensive CME Program

Pri-Med West

Download the Full Conference Brochure »

Primary Care Updates*
March 26, 2014
A multi-track day of CME programs to supplement your education. Earn up to 8 AMA PRA Category 1 Credits™ or 8 AANP contact hours of continuing education.

Annual Conference
March 27–29, 2014
An entirely new cutting-edge CME curriculum developed in collaboration with the American College of Physicians. Earn up to 19 AMA PRA Category 1 Credits™ or 19 AANP contact hours of continuing education.


Educational Symposia
Accredited CME sessions to expand your learning during breaks from the core ACP curriculum.


Industry-sponsored Opportunities

Exhibit Hall
Have face-to-face conversations with industry professionals, gain helpful takeaways, and experience engaging floor activities such as live demonstrations, outside your office hours. Learn More »

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.


Distribution of all additional opportunity tickets will happen on-site on a first-come, first-served basis at the Ticket Booth. Please check-in early to ensure tickets are available for the additional opportunities you want to participate in.

Presentation Theaters are not offered for CME credit nor is the content planned or reviewed by pmiCME or ACP.

 

Pri-Med Mobile App Available Now!

Sessions & Syllabus

For your convenience, we have printer-friendly syllabus slides available for you to download.

Print Primary Care Updates Syllabus

CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
Current Perspectives and Emerging Approaches in Lipid Management
Room: Ballroom A, Level 3
Learning Objectives:
  1. Evaluate primary and secondary prevention evidence with statins.
  2. Explain the importance of lowering LDL-C for reducing cardiovascular risk, interpret statin safety data, and assess benefit/risk with statins.
  3. Explain the association of hypertriglyceridemia with increased risks and identify currently available therapies for reducing elevated triglycerides.
  4. Discuss similarities and differences between currently available and emerging omega-3 fatty acid agents, and indicate patient populations for potential incorporation of omega-3 fatty acids in clinical practice.
Faculty:
  1. Eliot Brinton, MD, FAHA , FNLA, Associate Professor of Medicine, University of Utah School of MedicineSalt Lake City, UT (Bio)
  2. C. Noel Bairey Merz, MD, FACC, FAHA, Women's Guild Endowed Chair, Women's Health, Cedars-Sinai Medical Center Los Angeles, CA (Bio)
CLOSE  X  
Digesting the Facts in IBS: From Early Diagnosis to Effective Treatment Options
Room: Room 204, Level 2
Learning Objectives:
  1. Evaluate the necessity of diagnostic testing in individual patients prior to diagnosis of IBS.
  2. Choose appropriate nonpharmacologic or pharmacologic therapies to aid patients with IBS.
  3. Manage the symptoms of IBS over the long term through effective treatment strategies.
Faculty:
  1. Brian Lacy, MD, PhD, Professor of Medicine, Dartmouth Medical SchoolLebanon, NH, Chief, Section of Gastroenterology and Heptology, Dartmouth Hitchcock Medical CenterLebanon, NH (Bio)
  2. Spencer Dorn, MD, MPH, MHA, Assistant Professor of Medicine, Vice Chief of Gastroenterology, Lead Information Physician, EPIC, University of North Carolina Chapel Hill, NC
CLOSE  X  
The Evaluation and Treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in the Primary Care Setting
Room: Balllroom D, Level 3
Learning Objectives:
  1. Describe the pathophysiology and common comorbidities of BPH/LUTS.
  2. Implement comprehensive assessment of patients with BPH/LUTS.
  3. Select treatment options available to effectively treat BPH/LUTS.
Faculty:
  1. Martin Miner, MD, Chief of Primary Care and Community Medicine, Co-Director, Men's Health Center, The Miriam HospitalProvidence, RI, Co-Director, Men's Health Center, Clinical Associate Professor of Family Medicine and Urology, Warren Alpert Medical School, Brown UniversityProvidence, RI (Bio)
  2. Matt T Rosenberg, MD, Medical Director, Mid-Michigan Health CentersJackson, MI, Chief, Department of Family Medicine, Foote Health SystemJackson, MI
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
Managing the Patient with High Triglycerides: Assessment and Treatment Strategies
Room: Room 204, Level 2
Learning Objectives:
  1. Discuss the role of elevated triglyceride levels in the assessment and diagnosis of dyslipidemia, including cardiovascular risk factors.
  2. Apply best practices in the attainment of TG levels, including the role of fasting and non-fasting states in accurate evaluation.
  3. Evaluate the management of hypertriglyceridemia through greater adherence to evidenced based practices and accepted guidelines.
  4. Select potential new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk.
Faculty:
  1. John R Nelson, FACC , MD , FNLA, Director, California Cardiovascular InstituteGlendale, CA, Assistant Clinical Professor of Medicine - Volunteer, Fresno Medicine Residency Program, University of California San Francisco Diabetes CenterSan Francisco, CA
  2. Sergio Fazio, MD, PhD, FASCI , FAAP, Cornelius Vanderbilt Chair of Cardiovascular Medicine, Professor of Medicine and of Pathology, Immunology and Microbiology, Chief, Section of Cardiovascular Disease Prevention, Director, Vanderbilt Lipid Laboratory, Vanderbilt University Medical CenterNashville, TN
CLOSE  X  
Major Depression in the Primary Care Setting: Clinical Updates on Novel Strategies for Relapse Prevention and Sustained Recovery
Room: Balllroom D, Level 3
Learning Objectives:
  1. Identify residual symptoms of MDD and evaluate their impact on symptomatic remission and recovery.
  2. Review recent clinical updates on traditional and newer pharmacotherapies for MDD and their benefits/limitations in symptomatic remission and recovery .
  3. Examine the role of serotonin in the pathogenesis of MDD, including the significance of molecular targets in mitigating residual symptoms of depression.
Faculty:
  1. Larry Culpepper, MD, MPH, Professor of Family Medicine, Boston University School of MedicineBoston, MA, Staff Physician, Boston Medical CenterBoston, MA (Bio)
  2. Bradley Gaynes, MD, MPH, Professor of Psychiatry, Associate Chair for Research Training and Education, University of North Carolina School of MedicineChapel Hill, NC (Bio)
CLOSE  X  
AM Break
CLOSE  X  
The Role of Non-Invasive Cardiac Imaging in Primary Care: When and How To Use It
Room: Ballroom A, Level 3
Learning Objectives:
  1. Identify patients who are appropriate candidates for non-invasive cardiac imaging and cardiology referral.
  2. Recognize current guideline recommended indications for non-invasive cardiac imaging tests and apply them in the selection of appropriate tests for CV risk assessment.
  3. Describe the value and limitations of various non-invasive cardiac imaging techniques for cardiovascular risk stratification in patients with known or suspected coronary artery disease.
  4. Outline the differences between the pharmacologic stress agents used in conjunction with non-invasive cardiac imaging.
Faculty:
  1. Prem Soman, MD, PhD, FRCP, Associate Professor of Medicine (Cardiology), Director, Clinical and Translational Science, Nuclear Cardiology Director, Advanced Cardiac Imaging Fellowship, UPMC Heart and Vascular InstitutePittsburgh, PA (Bio)
  2. Saurabh Malhotra, MD, MPH, Clinical Instructor, UPMC Heart and Vascular InstitutePittsburgh, PA (Bio)
CLOSE  X  
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
Room: Balllroom D, Level 3
Learning Objectives:
  1. Summarize the clinical evidence supporting the use of basal insulin therapy, with and without GLP-1 receptor agonists, in the management of type 2 diabetes.
  2. Incorporate strategies to overcome barriers to insulin use in the treatment of type 2 diabetes.
Faculty:
  1. Frank Lavernia, MD, Founder, North Broward Diabetes CenterPompano Beach, FL (Bio)
  2. Carol Wysham, MD, Clinical Assistant Professor of Medicine, Section Head, Endocrinology, Rockwood Clinic, University of Washington School of MedicineSeattle, WA
  3. George Dailey, MD, Senior Consultant, Division of Diabetes & Endocrinology, Scripps ClinicLa Jolla, CA, Head Diabetes Research, Medical Director, Scripps Whittier Diabetes InstituteSan Diego, CA, Clinical Professor, Department of Medicine, University of California, San DiegoSan Diego, CA (Bio)
CLOSE  X  
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
Room: Room 204, Level 2
Learning Objectives:
  1. Summarize fundamental similarities and differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet drugs.
  2. Explain efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials.
  3. Recognize guideline-based therapies to reduce risk and goals to achieve in the management of patients who have experienced an acute coronary syndrome.
Faculty:
  1. James de Lemos, MD, Professor of Medicine, University of Texas Southwestern Medical SchoolDallas, TX (Bio)
  2. Karol Watson, MD, PhD, FACC, Professor of Medicine, University of California, Los AngelesLos Angeles, CA (Bio)
CLOSE  X  
Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
Room: Ballroom A, Level 3
Learning Objectives:
  1. Recognize the role of the renal system in glucose uptake, reabsorption, and the maintenance of glucose homeostasis and use the achieved knowledge to identify patients who would benefit from renally-targeted therapies.
  2. Explain the mechanism of action of sodium glucose linked transporter inhibitors and their role in modulating glucose homeostasis.
  3. Review professional guidelines from the ADA and AACE for target goals of therapy and treatment recommendations for specific patient-types.
  4. Identify the safety and efficacy profiles of current and emerging therapies that target renally-mediated glucose uptake and reabsorption.
  5. Implement management strategies that incorporate current and emerging therapies into treatment paradigms for patients who would benefit from a targeted approach to glycemic control.
Faculty:
  1. Jeff Unger, MD, Medical Director, The Unger Primary Care Medical CenterChino, CA
CLOSE  X  
Lunch
CLOSE  X  
Lunch
CLOSE  X  
Lunch
CLOSE  X  
Diabetic Eye Disease: Bridging the Gap in Patient Care
Room: Balllroom D, Level 3
Learning Objectives:
  1. Discuss with patients the impact of diabetes on eye health.
  2. Recognize the importance of glycemic control in the prevention and management of diabetic eye disease.
  3. Identify treatment options and general therapeutic outcomes for diabetic eye disease.
  4. Coordinate a referral and follow-up plan for patients with diabetes to an appropriate eye specialist.
Faculty:
  1. Ping Wang, MD, Professor of Medicine, UC Irvine School of Medicine, Director, UC Irvine Diabetes CenterIrvine, CA
  2. John Kitchens, MD, Ophthalmologist, Vitreoretinal Surgeon, Retina Associates of Kentucky, Adjunct Professor, University of Kentucky College of MedicineLexington, KY
CLOSE  X  
Insulin Therapy in Patients with Type 2 Diabetes: Current and Emerging Basal Insulins
Room: Room 204, Level 2
Learning Objectives:
  1. Outline the benefits of early insulin therapy in patients with type 2 diabetes.
  2. Discuss when insulin may be initiated for the treatment of patients with type 2 diabetes.
  3. Describe the advantages and disadvantages of various insulin regimens and apply them in clinical practice for the selection and titration of insulin in patients with type 2 diabetes.
  4. Identify the barriers to insulin-mediated glucose control and apply strategies to overcome them.
  5. Describe how improved pharmacokinetic and pharmacodynamic profiles of emerging insulins may reduce hypopglycemia and optimize insulin administration.
Faculty:
  1. Andrew Ahmann, MD, MS, Professor of Medicine, Director, Harold Schnitzer Diabetes Health Center, Oregon Health & Science UniversityPortland, OR
  2. Dace Trence, MD, FACE, Director, Diabetes Care Center, Professor, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medical CenterSeattle, WA
CLOSE  X  
Key Strategies for HPV Cancer Prevention
Room: Ballroom A, Level 3
Learning Objectives:
  1. Explain the epidemiology and burden of disease associated with HPV viruses.
  2. Identify those HPV types most often associated with particular cancers and genital warts.
  3. Discuss strategies to reduce the prevalence of these diseases.
  4. Discuss how vaccine safety is assessed and monitored.
Faculty:
  1. Rachel Caskey, MD, MPP, Program Director, Med-Peds, Associate Section Chief, General Internal Medicine, Associate Section Chief, General Pediatrics, University of Illinois at ChicagoChicago, IL
  2. Kenneth Alexander, MD , PhD, Professor of Pediatrics, Chief, Section of Pediatric Infectious Diseases, University of Chicago Chicago, IL
CLOSE  X  
PM Break
CLOSE  X  
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to Improve Patient Outcomes
Room: Balllroom D, Level 3
Learning Objectives:
  1. Describe the neurophysiologic mechanisms of circadian rhythms and adverse multisystem consequences of misalignment for patient health and function.
  2. Evaluate sleep patterns and symptoms of shift work disorder using clinical tools and strategies, such as sleep logs and the Epworth Sleepiness Scale.
  3. Diagnose shift work disorder based on identified symptoms, patient history and work schedule, and a comprehensive sleep history.
  4. Tailor therapeutic regimens for shift work disorder that include appropriate combinations of nonpharmacologic and pharmacologic modalities.
  5. Educate patients on the potential consequences of poorly managed shift work disorder and the fundamentals of sleep hygiene.
Faculty:
  1. Karl Doghramji, MD, Professor of Psychiatry, Neurology, and Medicine, Medical Director, Jefferson Sleep Disorders Center, Program Director, Fellowship in Sleep Medicine, Thomas Jefferson UniversityPhiladelphia, PA (Bio)
  2. Paul Doghramji, FAAFP , MD, Family Physician, Collegeville Family PracticeCollegeville, PA, Medical Director of Health Services, Ursinus CollegeCollegeville, PA (Bio)
  3. Charles Czeisler, MD, PhD, Baldino Professor of Sleep Medicine, Harvard Medical SchoolBoston, MA, Senior Physician, Division of Sleep Medicine, Department of Medicine, Brigham and Women's HospitalBoston, MA
CLOSE  X  
PM Break
CLOSE  X  
PM Break
CLOSE  X  
Tools for Diagnosis, Assessment, and Management of Chronic Obstructive Pulmonary Disease in Clinical Practice
Room: Room 204, Level 2
Learning Objectives:
  1. Utilize recommendations, such as those of GOLD and the COPD Foundation, for the diagnosis of COPD, including the use of spirometry and evaluation of symptoms.
  2. Evaluate and differentiate between standard COPD therapies for decreasing exacerbations and improving symptoms and other outcomes.
  3. Integrate recently approved agents into the COPD treatment armamentarium through evidence based decision-making.
Faculty:
  1. Jill Ohar, MD, Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine, Center for Genomics and Personalized Medicine Research, Comprehensive Cancer Center, Center for Worker Health, Director for Respiratory Therapy, Wake Forest Baptist HealthWinston-Salem, NC
  2. Fernando Martinez, MD, MS, Professor, Department of Internal Medicine, Director, Pulmonary Diagnostic Services, University of MichiganAnn Arbor, MI
CLOSE  X  
Five Things to Do Differently for Your Patients with Depression: Working Toward Successful Treatment
Room: Ballroom A, Level 3
Learning Objectives:
  1. Describe serotonergic pathways, including the benefits of specific therapeutic modulation of monoamine neurotransmission.
  2. Implement comprehensive antidepressant treatment strategies, incorporating both pharmacotherapy and psychotherapy, with the goal of sustained remission.
  3. Utilize antidepressants effectively based on their mechanism of action (MOA), onset of action, safety profile, and patient needs.
  4. Communicate effectively to patients the importance of adhering to medications and expectations of treatment.
Faculty:
  1. Vladimir Maletic, MD, MS, Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of MedicineColumbia, SC, Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke UniversityDurham, NC
  2. Charles Raison, MD, Associate Professor, Department of Psychiatry, College of Medicine, John and Doris Norton School of Family and Consumer Sciences, University of ArizonaTucson, AZ
CLOSE  X  
Rare Cases in Angioedema: Lifting the Veil on a Potentially Fatal Disease
Room: Balllroom D, Level 3
Learning Objectives:
  1. Describe epidemiology, pathophysiology, and burden of illness of HAE.
  2. Recognize HAE as a possible cause of recurrent angioedema and formulate an appropriate diagnostic workup for various types of HAE (Type I, Type II, and normal C1-INH).
  3. Utilize individualized HAE treatment strategies, taking into consideration risks and benefits of therapies, disease characteristics and severity, comorbid conditions, patient quality of life and patient preference.
Faculty:
  1. Marc Riedl, MD , MS, Clinical Director, US HAEA Angioedema Center, University of CaliforniaSan Diego, CA
  2. William Lumry, MD, FACP, FAAAAI, Clinical Professor of Internal Medicine, University of Texas Southwestern Medical SchoolDallas, TX
CLOSE  X  
Current Challenges in the Diagnosis and Management of Chronic Idiopathic Urticaria
Room: Room 204, Level 2
Learning Objectives:
  1. Discuss the epidemiology and typical physiologic and socioeconomic sequelae associated with CIU.
  2. Describe current challenges associated with pharmacotherapy for treating CIU.
  3. Compare and contrast the various treatment strategies commonly employed in patients with CIU.
  4. Evaluate the utility of adjunctive or novel therapies for treating CIU.
Faculty:
  1. Stephen Dreskin, MD, Professor of Medicine and Immunology, University of Colorado Denver, Director of the Allergy and Immunology Practice, University of Colorado HospitalDenver, CO
  2. Tan Nguyen, MD, Clinical Assistant Professor, UC Irvine School of Medicine, Family Medicine Specialist, UC Irvine HealthIrvine, CA
CLOSE  X  
For Your Eyes Only - Ophthalmology 2014 Update
Room: Ballroom A, Level 3
Learning Objectives:
  1. Discuss the latest results of the CATT trial and the AREDS2 trial their implications for age-related macular degeneration
  2. Describe how to minimize the risk of ophthalmic adverse events in patients taking alpha-blockers for prostate disease.
  3. Discuss 2 new imaging modalities designed to help primary care clinicians and ophthalmologists diagnose eye disease.
Faculty:
  1. Tommy Korn, MD, FACS, Attending Ophthalmologist, Sharp Rees-Stealy Medical Group, Sharp Memorial HospitalSan Diego, CA (Bio)
Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: AstraZeneca, Astellas Pharma US, Inc, Merck & Co., Inc. and Forest Laboratories, Inc.
Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com, Takeda Pharmaceuticals International, Inc., U.S. Region and Lundbeck Pharmaceutical Services, LLC, Novo Nordisk Inc., Genentech, Teva CNS and Shire ViroPharma Incorporated.
Primary Care Updates Track 3
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 3: Forest Laboratories, Inc. and Ironwood Pharmaceuticals, Supported by an educational grant from Amarin Pharma, Inc., AstraZeneca, Sanofi US Diabetes, Forest Laboratories, Inc. and Genentech.
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
4:15PM
 
4:45PM
 
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
   
   
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:45 AM-9:15 AM
Current Perspectives and Emerging Approaches in Lipid Management
7:45 AM-9:00 AM
The Evaluation and Treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in the Primary Care Setting
7:45 AM-9:00 AM
Digesting the Facts in IBS: From Early Diagnosis to Effective Treatment Options
   
   
   
   
 
9:00 AM-9:15 AM - AM Break
9:00 AM-9:15 AM - AM Break
9:15 AM-9:30 AM - AM Break
9:15 AM-10:30 AM
Major Depression in the Primary Care Setting: Clinical Updates on Novel Strategies for Relapse Prevention and Sustained Recovery
9:15 AM-10:30 AM
Managing the Patient with High Triglycerides: Assessment and Treatment Strategies
9:30 AM-11:00 AM
The Role of Non-Invasive Cardiac Imaging in Primary Care: When and How To Use It
  
   
   
   
 
10:30 AM-12:00 PM
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
10:30 AM-12:00 PM
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
   
11:00 AM-12:15 PM
Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
  
   
   
   
 
12:00 PM-12:45 PM - Lunch
12:00 PM-12:45 PM - Lunch
12:15 PM-1:00 PM - Lunch
  
   
 
12:45 PM-2:00 PM
Diabetic Eye Disease: Bridging the Gap in Patient Care
12:45 PM-2:15 PM
Insulin Therapy in Patients with Type 2 Diabetes: Current and Emerging Basal Insulins
1:00 PM-2:15 PM
Key Strategies for HPV Cancer Prevention
  
   
   
   
 
2:00 PM-2:15 PM - PM Break
 
2:15 PM-2:30 PM - PM Break
2:15 PM-3:30 PM
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to Improve Patient Outcomes
2:15 PM-2:30 PM - PM Break
2:30 PM-4:00 PM
Five Things to Do Differently for Your Patients with Depression: Working Toward Successful Treatment
 
2:30 PM-3:45 PM
Tools for Diagnosis, Assessment, and Management of Chronic Obstructive Pulmonary Disease in Clinical Practice
   
   
   
 
3:30 PM-4:45 PM
Rare Cases in Angioedema: Lifting the Veil on a Potentially Fatal Disease
 
  
3:45 PM-5:00 PM
Current Challenges in the Diagnosis and Management of Chronic Idiopathic Urticaria
4:00 PM-5:00 PM
For Your Eyes Only - Ophthalmology 2014 Update
  
   
   
   
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
Room: Hall C, Level 1
Getting your patients to lose weight is never easy. Learn in this keynote address from the weight loss and nutrition consultant to NBC's "The Biggest Loser" about effective lifestyle and behavioral approaches to achieve weight loss goals in your overweight and obese patients.
Learning Objectives:
  1. Employ proven, evidence-based lifestyle and behavioral modalities to help your obese patients lose weight and achieve health benefits.
Faculty:
  1. Michael Dansinger, MD, Director of the Diabetes Reversal Program, Tufts Medical CenterBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Targeting Better Cardiac Outcomes for High-Risk Patients
Room: Ballroom A, Level 3
This session will provide important update information on low HDL-C levels and elevated triglycerides as therapeutic targets to reduce cardiovascular disease risk.
Learning Objectives:
  1. Evaluate recent clinical trials with respect to management of low HDL.
  2. Examine the data on triglycerides and CVD risk to determine how aggressively to treat patients with elevated TGs.
  3. Employ strategies for reducing CVD risk in patients with type 2 diabetes and hypertension.
Faculty:
  1. Daniel Soffer, MD, Physician, Preventive Cardiovascular Medicine, Penn Medicine at Radnor, Perelman Center for Advanced Medicine, University of Pennsylvania Health SystemPhiladelphia, PA (Bio)
CLOSE  X  
Live Demonstration Orthopedic Exam: See It, Do it
Room: Hall C, Level 1
Learn orthopedic maneuvers to assess common office-based musculoskeletal complaints.
Learning Objectives:
  1. Through live demonstration of orthopedic maneuvers, you will improve your ability to diagnose common musculoskeletal complaints of the upper body, low back, hip, and knee.
Faculty:
  1. M. Susan Burke, MD, FACP, Clinical Associate Professor of Medicine, Thomas Jefferson UniversityPhiladelphia, PA, Senior Advisor, Lankenau Medical Associates, Lankenau Medical CenterWynnewood, PA (Bio)
CLOSE  X  
Office Dermatology
Room: Ballroom D, Level 3
Learning Objectives:
  1. Aid in the diagnosis of common skin disorders seen in the outpatient setting.
  2. Familiarize the Primary Care Provider with appropriate management of common skin disorders.
  3. Assist the Primary Care Provider with knowing when specialty consultation is needed.
Faculty:
  1. Jennifer Haley, MD, Associate Clinical Professor of Medicine/Dermatology, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
Common Eye Disorders in Primary Care
Room: Ballroom D, Level 3
Learning Objectives:
  1. Understand the urgency of referral to an ophthalmologist or an emergency facility for specific sight or life-threatening conditions.
  2. Describe the differential diagnosis of the red eye.
  3. Identify the components of an office-based screening evaluation for eye disease.
Faculty:
  1. Lynn Gordon, MD, Professor of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
Room: Ballroom A, Level 3
This session will provide new insight into the pathogenesis of dyslipidemia in the type 2 diabetic patient with chronic kidney disease and the rationale for advanced lipid testing (i.e., lipoprotein particle analysis) in those patients at high CV risk.
Learning Objectives:
  1. Describe the pathogenesis of dyslipidemias in patients with diabetes and chronic kidney disease.
  2. Understand the rationale for performing lipoprotein particle analysis in patients with high CV risk comorbidities.
Faculty:
  1. Matthew Sorrentino, FASH , MD, FACC, Professor of Medicine, Department of Medicine, Section of Cardiology, University of Chicago Pritzker School of MedicineChicago, IL (Bio)
CLOSE  X  
Office Nephrology: What To Do with the Patient with Newly Diagnosed CKD III ?
Room: Ballroom D, Level 3
Learning Objectives:
  1. Screen for and identify patients with early stages (1-3) chronic kidney disease (CKD).
  2. Discuss strategies for delaying or preventing the progression of CKD.
  3. Assess and integrate the known increased cardiovascular risk associated with CKD.
  4. Identify and stratify renal risk in various ethnic and cultural populations.
Faculty:
  1. Edwin Jacobson, MD, Clinical Professor of Medicine, David Geffen School of Medicine, University of California, Los AngelesLos Angeles, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
Room: Hall C, Level 1
Practicing clinicians face the challenge of evaluating patients for aberrant drug behavior when prescribing opioid therapy for pain management. This session will help improve your ability to identify risk factors for drug-seeking behaviors and to differentiate between opioid tolerance, physical dependence and addiction.
Learning Objectives:
  1. Identify risk factors for opioid-related aberrant behavior.
  2. Differentiate between tolerance, physical dependence and addiction.
Faculty:
  1. Charles Argoff, MD, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
Room: Ballroom A, Level 3
Participatory medicine is being driven by e-health technology and represents a significant paradigm shift. Learn how e-messaging, patient health records/patient portals and online resources can improve and are improving patient care through improved communication between you and your patients.
Learning Objectives:
  1. Take advantage of online resources to expand your medical knowledge and augment your clinical expertise.
  2. Provide practical advice to patients about smart and appropriate use of web-based health information and social media.
Faculty:
  1. Daniel Sands, MD, MPH, Assistant Clinical Professor of Medicine, Harvard Medical SchoolBoston, MA, Attending Physician, Beth Israel Deaconess Medical CenterBoston, MA (Bio)
CLOSE  X  
Heart Failure: State-of-the-Art
Room: Ballroom D, Level 3
Learning Objectives:
  1. Describe current evidence-based guideline recommendations for heart failure therapy.
  2. Describe the impact of medical therapies on heart failure patient outcom.
  3. Describe the benefits of device therapy on heart failure management.
Faculty:
  1. Gregg Fonarow, MD, Eliot Corday Professor of Cardiovascular Medicine and Science, Division of Cardiology, UCLALos Angeles, CA, Director, Ahmanson-UCLA Cardiomyopathy Center, Co-Director, UCLA Preventative Cardiology Program, UCLA Medical CenterLos Angeles, CA (Bio)
CLOSE  X  
Diagnosing and Treating Thyroid Disorders
Room: Ballroom D, Level 3
Learning Objectives:
  1. Understand that 10% of women at the age 80 can have hypothyroidism.
  2. Identify risk factors associated with hyperthyroidism such as new onset atrial fibrillation, anxiety disorder, psychosis, and osteoporosis.
  3. Understand the need to measure both a FT4 and TSH in all hospitalized patients with symptoms consistent with hypothyroidism.
  4. Make the correct treatment decision based on TSH and Ft4 lab values and associated long term risk.
Faculty:
  1. John Tayek, MD, Professor of Medicine - In Residence, David Geffen School of Medicine at UCLALos Angeles, CA, Director of Community Health Plan, Internal Medicine, Harbor UCLA Medical CenterTorrance, CA
CLOSE  X  
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
Room: Hall C, Level 1
Improve your ability to adjust treatment when converting from immediate release opioid formulations to extended release/long-acting preparations, as well as your ability to identify risk factors for opioid-induced respiratory depression.
Learning Objectives:
  1. Convert patients from immediate-release to ER/LA opioids as well as from one ER/LA opioid to another
  2. Identify predisposing risk factors for significant respiratory depression
Faculty:
  1. Bill McCarberg, MD, Founder, Chronic Pain Management Program, Kaiser Permanente San Diego, CA (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Test Your Skills in Difficult Cases: Atrial Fibrillation
Room: Ballroom A, Level 3
This session will provide important take away information on the use of anticoagulant therapy in afib patients that is evidence and guideline based. Also included will be approaches to differentiate between rate and rhythm control that can direct appropriate treatment strategies.
Learning Objectives:
  1. Describe current guidelines and clinical evidence regarding the use of anticoagulant therapy in patients with atrial fibrillation (AF).
  2. Differentiate between rate and rhythm control in AF and direct appropriate treatment strategies based on these parameters.
Faculty:
  1. Jordan Prutkin, MD, MHS, Assistant Professor of Medicine, Division of Cardiology/Electrophysiology, University of Washington Seattle, WA
CLOSE  X  
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
Room: Hall C, Level 1
Improve your ability to manage adverse reactions with extended release/long-acting opioid formulations and to monitor patient adherence to treatment.
Learning Objectives:
  1. Evaluate and manage adverse effects of ER/LA-opioids.
  2. Differentiate strategies for monitoring patient adherence.
Faculty:
  1. Bill McCarberg, MD, Founder, Chronic Pain Management Program, Kaiser Permanente San Diego, CA (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Approach to Rheumatologic Diagnosis
Room: Ballroom D, Level 3
Learning Objectives:
  1. Identify the target tissue of inflammation and distribution of affected joints.
  2. Categorize an arthritic presentation as degenerative, inflammatory or non-inflammatory.
  3. Understand the role of imaging and laboratory studies in making an arthritis diagnosis.
Faculty:
  1. Peng Fan, MD, Clinical Professor of Medicine/Rheumatology, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
Networking Break
CLOSE  X  
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
Room: Ballroom A, Level 3
Sequential insulin strategies recommended by the ADA/EASD will be reviewed, and evidence-based insulin regimens will be provided that can be used to initiate treatment that gets type 2 diabetic patients to their A1c goals.
Learning Objectives:
  1. Describe the sequential insulin strategies approach recommended by recent guidelines.
  2. Apply evidence-based insulin strategies to help patients with type 2 diabetes achieve their HbA1C goals.
Faculty:
  1. Javier Morales, MD, St. Francis Hospital, Advanced Internal Medicine GroupNew Hyde Park, NY, Advanced Internal Medicine Group, PC, Advanced Internal Medicine GroupNew Hyde Park, NY (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
Room: Hall C, Level 1
This session will provide important take away strategies for counseling patients and caregivers to ensure appropriate use of extended release/long-acting opioids and recognition of signs of overdose.
Learning Objectives:
  1. Implement counseling strategies to ensure patients know to take ER/LA opioids exactly as prescribed.
  2. Use counseling strategies to explain signs of ER/LA opioid overdose to patients and caregivers.
Faculty:
  1. Steven Stanos, DO, Medical Director, Center for Pain Management, Rehabilitation Institute of ChicagoChicago, IL, Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Menopause Hormone Therapy: Where Are We Now?
Room: Ballroom D, Level 3
Learning Objectives:
  1. Understand clinician knowledge gaps regarding menopausal hormone therapy.
  2. Review the latest safety information on oral and vaginal hormone therapy for menopausal symptoms.
  3. Become familiar with nonhormone therapies for menopausal symptoms.
Faculty:
  1. Carolyn Crandall, MD, Professor of Medicine, Iris Cantor-UCLA Women’s Health Center, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
Room: Hall C, Level 1
When individualizing your pain management treatment approach, learn how to assess differences in opioid metabolism and potential drug interactions in your patient, and how these factors will impact treatment.
Learning Objectives:
  1. Assess the differences in opioid metabolism and how these impact appropriate ER/LA prescribing
  2. Identify how opioid-drug interactions influence ER/LA opioid prescribing.
Faculty:
  1. Steven Stanos, DO, Medical Director, Center for Pain Management, Rehabilitation Institute of ChicagoChicago, IL, Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Alcoholism: Recognition and Management
Room: Ballroom D, Level 3
Learning Objectives:
  1. Use screening instruments to identify patients with risky and harmful drinking.
  2. Employ brief techniques for motivational interviewing for alcohol disorders.
  3. Tailor treatment of alcohol use disorders with appropriate drug therapies.
  4. Differentiate patient placement criteria for inpatient, outpatient, and residential treatment of alcohol use disorders.
Faculty:
  1. Timothy Fong, Associate Professor of Psychiatry, Co Director, UCLA Gambling Studies Program, Director, UCLA Addication Psychiatry Fellowship, Director, UCLA Addication Medicine Clinic, University of California at Los AngelesLos Angeles, CA
CLOSE  X  
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
Room: Ballroom A, Level 3
Elderly patients with dementia present the practicing physician with the challenge of managing the psychiatric and behavioral spectrum of this disorder: memory problems, mood disorders, sleep disturbances, apathy, delusions, hallucinations, wandering and agitation. This session will provide assistance in the differential diagnosis and the selection of appropriate pharmacologic and non-pharmacologic treatments for behavioral problems.
Learning Objectives:
  1. Differentiate the variation in symptoms of the dementing disorders depending upon their etiology.
  2. Apply appropriate pharmacologic therapies for behavioral problems associated with dementia.
  3. Apply appropriate non-pharmacological therapies for agitation with special attention to the environment.
Faculty:
  1. Joshua Chodosh, MD , MSHS , FACP, Associate Professor in Residence, Division of Geriatrics, Department of Medicine, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
Room: Hall C, Level 1
Improve your understanding of the official prescribing information for available extended release/long-acting opioids, as well as the doses indicated for opioid-tolerant patients.
Learning Objectives:
  1. Differentiate the prescribing information among available ER/LA opioids.
  2. Identify ER/LA opioids and dosages indicated for opioid-tolerant patients only.
Faculty:
  1. Charles Argoff, MD, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Obesity: Meeting the Challenge
Room: Ballroom D, Level 3
Learning Objectives:
  1. Understand the relationship between calories and weight.
  2. Develop positive treatment approaches that foster self-management and encourage healthy lifestyle changes in patients who are obese.
Faculty:
  1. Richard Johnson, MD, Clinical Professor of Family Medicine, David Geffen School of Medicine at UCLALos Angeles, CA, President, Pacific Palisades Medical Group, Inc.Pacific Palisades, CA (Bio)
CLOSE  X  
Medical Brain Game: SAFE Opioid Prescribing Edition
Room: Hall C, Level 1
This session makes use of an engaging quiz show format to reinforce the essential elements in the appropriate use of opioids in pain management.
Learning Objectives:
  1. Compete in this practical, REMS-themed medical knowledge game, sure to provide a fun challenge.
Faculty:
  1. Charles Argoff, MD, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
  2. Bill McCarberg, MD, Founder, Chronic Pain Program, Kaiser PermanenteSan Diego, CA (Bio)
  3. Steven Stanos, DO, Medical Director, Center for Pain Management, Rehabilitation Institute of ChicagoChicago, IL, Assistant Professor, Department of Physical Medicine and Rehabilitation, Assistant Program Director, Multidisciplinary Pain Fellowship, Northwestern University Feinberg School of MedicineChicago, IL (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-11:45 AM
Live Demonstration Orthopedic Exam: See It, Do it
9:45 AM-10:45 AM
Targeting Better Cardiac Outcomes for High-Risk Patients
9:45 AM-10:25 AM
Office Dermatology
 
10:25 AM-11:05 AM
Common Eye Disorders in Primary Care
 
10:45 AM-11:45 AM
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
11:05 AM-11:45 AM
Office Nephrology: What To Do with the Patient with Newly Diagnosed CKD III ?
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:30 PM
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
1:45 PM-2:45 PM
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
1:45 PM-2:25 PM
Heart Failure: State-of-the-Art
 
2:25 PM-3:05 PM
Diagnosing and Treating Thyroid Disorders
2:30 PM-3:00 PM
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
2:45 PM-3:45 PM
Test Your Skills in Difficult Cases: Atrial Fibrillation
3:00 PM-3:45 PM
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
3:05 PM-3:45 PM
Approach to Rheumatologic Diagnosis
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-4:30 PM
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
4:00 PM-5:00 PM
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
4:00 PM-4:40 PM
Menopause Hormone Therapy: Where Are We Now?
 
4:30 PM-5:00 PM
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
4:40 PM-5:20 PM
Alcoholism: Recognition and Management
 
5:00 PM-5:30 PM
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
5:00 PM-6:00 PM
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
5:20 PM-6:00 PM
Obesity: Meeting the Challenge
5:30 PM-6:00 PM
Medical Brain Game: SAFE Opioid Prescribing Edition
 
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Clinical Assessment of the Older Patient for Driving Fitness
Room: Hall C, Level 1
* This activity meets the criteria of the California Board of Medicine in Medicine for 1 credit of Geriatric Medicine. Please check your individual state licensing board requirements before claiming Geriatric Medicine credit. ** pmiCME designates the session; Clinical Assessment of the Older Patient for Driving Fitness, for 1.0 credit of Geriatric Medicine.
Learning Objectives:
  1. Identify conditions that may put patients at risk for unsafe driving
  2. Name the clinical screens to evaluate patients’ level of function for driving fitness
  3. State referral and treatment options for patients who require further evaluation or are no longer fit to drive
  4. Demonstrate familiarity with California DMV reporting methods and requirements
Faculty:
  1. Linda Hill, MD, Clinical Professor, Department of Family and Preventive Medicine, University of California, San DiegoSan Diego, CA, Associate Professor of Health Promotion, Graduate School of Public Health, San Diego StateSan Diego, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
Room: Hall C, Level 1
This session will provide guidance on whom to screen for obstructive sleep apnea in your primary care practice, how to screen, interventions and the differences you will encounter between male and female patients with this condition.
Learning Objectives:
  1. Implement practice-based procedures to screen and manage patients at risk for or with evidence of obstructive sleep apnea.
  2. Co-manage patients with OSA and encourage continued monitoring and compliance with CPAP therapy.
Faculty:
  1. Jonathan Lown, MD, Adjunct Faculty, Stony Brook UniversityStony Brook, NY (Bio)
CLOSE  X  
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
Room: Ballroom A, Level 3
Improve your recognition of the signs and symptoms of major depressive disorder with differentiation from bipolar disorder. Improve your knowledge in the best practice selection of pharmacologic treatments for patients with uncomplicated depression and somatization.
Learning Objectives:
  1. Recognize the signs and symptoms of major depressive disorder (MDD) and initiate therapy with close monitoring.
  2. Differentiate bipolar disease from symptoms of depression in order to determine appropriate treatment.
  3. Consider actions and side effects of drugs and drug classes when deciding on which treatment to select for patients with psychiatric disorders.
Faculty:
  1. Rosalind Kaplan, FACP, MD, Director, Temple Health Women's Care, Temple University School of MedicinePhiladelphia, PA (Bio)
CLOSE  X  
Hypertension: JNC 8 and Beyond
Room: Ballroom D, Level 3
Learning Objectives:
  1. Discuss the new hypertension guidelines.
  2. Evaluate lifestyle modification and medical therapies for the treatment of hypertension.
  3. Review therapeutic options for treating resistant hypertension.
  4. Describe new interventional options to treat resistant hypertension.
Faculty:
  1. Karol Watson, MD, PhD, FACC, Assistant Professor of Medicine, Division of Cardiology, Director, UCLA Center for Cholesterol and Hypertension Management, Director, UCLA Women's Cardiovascular Center, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
New Drugs for the Primary Care Provider: What You Need to Know
Room: Ballroom D, Level 3
Learning Objectives:
  1. Learn which recently approved drugs will have the largest impact on primary care practice.
  2. Understand the efficacy, side effects, and cost of important novel drugs in primary care practice.
  3. Learn the role of recently approved medications and their place among existing therapies.
Faculty:
  1. Gerald Smetana, MD, Professor of Medicine, Harvard Medical SchoolBoston, MA, Practicing Internist and Educator, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical CenterBoston, MA (Bio)
CLOSE  X  
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
Room: Hall C, Level 1
Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis and pulmonary embolism. This session will assist you in identifying high risk medical and hospitalized patients in whom thromboprophylaxis should be initiated and appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Learning Objectives:
  1. Identify high risk medical and hospitalized patients for whom thromboprophylaxis should be initiated.
  2. Determine appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Faculty:
  1. Matthew Rondina, MD, Assistant Professor, University Of Utah Salt Lake City, UT, Co-Director, Healthcare Thrombosis Service, University Of Utah Salt Lake City, UT (Bio)
CLOSE  X  
Critical Caveats for Common Medications
Room: Ballroom A, Level 3
Case-based review of side effects and drug interactions encountered with commonly used medications, including proton pump inhibitors, triptans, antibiotics, anticoagulants, NSAIDs and antidepressants.
Learning Objectives:
  1. Effectively manage patients who are on statin therapy with respect to potential drug interactions and muscle-related symptoms.
  2. Consider potential adverse effects of proton pump inhibitors, such as impaired absorption of certain nutrients, when prescribing as long-term therapy.
Faculty:
  1. Genevieve Pagalilauan, Associate Professor, Department of Medicine, Rainier College
CLOSE  X  
Ethical Challenges in the Elderly
Room: Ballroom D, Level 3
Learning Objectives:
  1. Implement advance care planning models and structures that improve care toward the end of life.
  2. Utilize tools to enhance planning for appropriate care toward the end of life.
  3. Facilitate decision making that reduces conflict, avoids inappropriate treatment, and is in the best interest of the patient.
Faculty:
  1. Neil Wenger, MD, Professor, Medicine/Cardiology, Director, UCLA Health Ethics Center, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Lipid Management: A Primary Care Perspective
Room: Hall C, Level 1
Be up to date on current studies evaluating the benefits of raising HDL in reducing CV risk and how intense treatment should be to reduce residual risk for CHD.
Learning Objectives:
  1. Utilize evidence-based lipoprotein management strategies for non-LDL-C lipid targets
  2. Describe the risk factors, disease spectrum, and appropriate management of familial hypercholesterolemia.
Faculty:
  1. Richard Wright, MD, FACC, President, Pacific Heart InstituteSanta Monica, CA (Bio)
CLOSE  X  
Infectious Diseases Update in Primary Care
Room: Ballroom A, Level 3
This infectious disease update session provides guidance on applying current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis, differential diagnosis and management of latent tuberculosis infection, and evidence-based management of genital herpes.
Learning Objectives:
  1. Apply current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis.
  2. Differentiate the diagnosis of latent tuberculosis infection from that of active tuberculosis.
  3. Apply current evidence and guidelines to the clinical management of genital herpes.
Faculty:
  1. Kalpana Gupta, MD, MPH, Associate Professor of Medicine, Boston University School of MedicineBoston, MA (Bio)
CLOSE  X  
Approach to the Patient With Syncope
Room: Ballroom D, Level 3
Learning Objectives:
  1. Describe the pathophysiology of syncope.
  2. Use appropriate diagnostic approaches to evaluate patients with syncope.
  3. Employ proven management strategies in the treatment of syncope.
Faculty:
  1. Jon Kobashigawa, MD, Associate Director, Cedars-Sinai Heart Institute, Director, Advanced Heart Disease Section, Cedars Sinai Medical CenterLos Angeles, CA, Director, Heart Transplant Program, Cedars Sinai Medical CenterLos Angeles, CA (Bio)
CLOSE  X  
"Eat, Drink, Pray" - Foodborne Infections the 21st century
Room: Ballroom D, Level 3
Learning Objectives:
  1. Learn about the changing domestic and global epidemiology of food-borne disease and federal tracking systems for food-borne illness.
  2. Become familiar with common food-borne toxins.
  3. Review safe handling of food in the home.
  4. Understand the risks that certain foods such as raw milk products and shellfish pose to certain patient populations.
Faculty:
  1. Claire Panosian, MD, Clinical Professor of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
Room: Hall C, Level 1
This session will provide actionable information for implementing current evidence-based guidelines to reduce CVD risk in type 2 diabetes patients and will utilize a case-based approach that addresses CV risk factors such a dyslipidemia and hypertension in these patients.
Learning Objectives:
  1. Identify key factors associated with increased cardiovascular outcomes in patients with type 2 diabetes
  2. Implement current evidence-based guidelines to reduce the risk of CV disease in patients with type 2 diabetes mellitus
Faculty:
  1. Michael Bloch, MD, FACP, FASH, Associate Professor, Department of Internal Medicine, University of Nevada School of MedicineReno, NV, Medical Director, Vascular Medicine and Anticoagulation Services, Renown Heart and Vascular InstituteReno, NV (Bio)
CLOSE  X  
Finding Clinical Value in EHR Meaningful Use
Room: Ballroom A, Level 3
Many physicians are wary of the time and resource commitment to implementing an EHR in their practice. This session will provide tangible examples of the value of EHRs and meaningful use in your practice, with suggestions for next steps in their use.
Learning Objectives:
  1. Understand the rationale for and intentions of Meaningful Use.
  2. Identify examples creating value from EHRs and Meaningful Use.
Faculty:
  1. Peter Basch, MD, Medical Director, Ambulatory EHR and Health IT Policy, Medical Director, MedStar Million HeartsWashington DC, DC (Bio)
CLOSE  X  
Common Injuries of the Hand and Wrist
Room: Ballroom D, Level 3
Learning Objectives:
  1. Review anatomical structures of the wrist and hand and common mechanisms of injury.
  2. Employ appropriate imaging procedures for wrist and hand injuries diagnoses.
  3. Use evidence based recommendations to treat common wrist and hand injuries.
Faculty:
  1. James Puffer, MD, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
Networking Break
CLOSE  X  
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
Room: Ballroom A, Level 3
Cardiovascular health is increasingly becoming an issue in long-term cancer survivors, requiring closer attention to its management. Learn how to assess and address cardiovascular risk in cancer survivors.
Learning Objectives:
  1. Explore the evidence regarding cardiovascular disease in survivors of certain types of cancer.
  2. Encourage cancer survivor patients to adopt healthy lifestyles to reduce CV and cancer risk.
  3. Implement screening guidelines for cancer survivors to reduce future cancer risk.
Faculty:
  1. Kevin Oeffinger, MD, Dir., Living Beyond Cancer: A Program for Adult Survivors of Pediatric Cancer, Departments of Pediatrics and Internal Medicine, Memorial Sloan-Kettering Cancer CenterNew York, NY (Bio)
CLOSE  X  
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
Room: Hall C, Level 1
This session will provide you with actionable information regarding insect pest borne infectious diseases, including the topic of the manifestations of Lyme disease and test interpretation to manage these patients and identifying body lice infestation with patient education regarding treatment and prevention.
Learning Objectives:
  1. Differentially diagnose common tick-borne diseases using symptomology, epidemiologic evidence, and lab tests, and prescribe antibiotic therapy as indicated.
  2. Diagnose and manage clinical manifestations of common pest infestations, including lice, mites, and bed bugs.
Faculty:
  1. Stephen Gluckman, MD, Professor of Medicine, Perelman School of Medicine, University of PennsylvaniaPhiladelphia, PA, Medical Director, Penn Global MedicinePhiladelphia, PA (Bio)
CLOSE  X  
Headaches in Primary Care
Room: Ballroom D, Level 3
Learning Objectives:
  1. Outline an approach to lifestyle management and trigger avoidance for migraine.
  2. Learn which complementary and alternative physical and pharmacologic treatments are helpful for migraine.
  3. Determine which abortive treatments for migraine are most effective.
  4. Learn a proper sequence of preventive medications for the treatment of migraine.
Faculty:
  1. Gerald Smetana, MD, Professor of Medicine, Harvard Medical SchoolBoston, MA, Practicing Internist and Educator, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical CenterBoston, MA (Bio)
CLOSE  X  
Common ENT Problems in Primary Care
Room: Ballroom D, Level 3
Learning Objectives:
  1. Identify common ENT problems and their presentation.
  2. Understand basic workup and management of these conditions.
  3. Recognize when referral for specialty evaluation and/or treatment may be indicated
Faculty:
  1. Paul Kedeshian, MD, Associate Clinical Professor, Division of Head and Neck Surgery, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic
Room: Hall C, Level 1
Non-alcoholic fatty liver disease is seen in many patients who are overweight or obese, or have diabetes, high cholesterol or high triglycerides. This session will review the spectrum of this condition, risk factors, referral advice, and application of the most current evidence-based recommendations for management.
Learning Objectives:
  1. Identify the risk factors and disease spectrum of non-alcoholic fatty liver disease.
  2. Apply the latest evidence-based recommendations for the management of NAFLD.
  3. Understand the indications for liver biopsy and further investigation.
Faculty:
  1. Elliot Tapper, Instructor in Medicine, Harvard Medical SchoolBoston, MA (Bio)
CLOSE  X  
Contraception Update: 2014
Room: Ballroom D, Level 3
Learning Objectives:
  1. Tailor contraceptive options according to patient needs and preferences, and counsel on appropriate use.
  2. Know how to prescribe emergency contraception.
Faculty:
  1. Martin Quan, MD, Professor of Clinical Family Medicine, Director, Office of Continuing Medical Education, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Clinical Assessment of the Older Patient for Driving Fitness
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
9:45 AM-10:45 AM
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
9:45 AM-10:25 AM
Hypertension: JNC 8 and Beyond
 
10:25 AM-11:05 AM
New Drugs for the Primary Care Provider: What You Need to Know
 
10:45 AM-11:45 AM
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
10:45 AM-11:45 AM
Critical Caveats for Common Medications
11:05 AM-11:45 AM
Ethical Challenges in the Elderly
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:45 PM
Lipid Management: A Primary Care Perspective
1:45 PM-2:45 PM
Infectious Diseases Update in Primary Care
1:45 PM-2:25 PM
Approach to the Patient With Syncope
 
2:25 PM-3:05 PM
"Eat, Drink, Pray" - Foodborne Infections the 21st century
 
2:45 PM-3:45 PM
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
2:45 PM-3:45 PM
Finding Clinical Value in EHR Meaningful Use
3:05 PM-3:45 PM
Common Injuries of the Hand and Wrist
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-5:00 PM
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
4:00 PM-6:00 PM
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
4:00 PM-4:40 PM
Headaches in Primary Care
 
4:40 PM-5:20 PM
Common ENT Problems in Primary Care
 
5:00 PM-6:00 PM
Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic
5:20 PM-6:00 PM
Contraception Update: 2014
 
 
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Mission Control: Medical Excellence
Room: Hall C, Level 1
This year's keynote address will be delivered by Dr. Story Musgrave, physician astronaut, who flew on each of the 5 different NASA space shuttles and led the first repair mission to the Hubble Space Telescope. With his broad educational background that includes mathematics, operational analysis, chemistry, literature, and cardiovascular and exercise physiology, Dr. Musgrave will provide his unique perspective on the mission of achieving clinical success and optimal patient outcomes.
Learning Objectives:
  1. Consider care of all patients as an urgent mission with critical outcomes.
  2. Lead your team to ensure optimal patient outcomes through spirit, ownership, and passion for the mission.
  3. Apply the best practices, procedures, and processes to guarantee that your path to clinical success is the best available.
Faculty:
  1. Story Musgrave, MD , MS, Astronaut, NASA, Innovator, Applied Minds Inc., Professor of Design, Art Center College of DesignPasadena, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Women’s Health Update: Clinical Pearls for Primary Care
Room: Hall C, Level 1
A review of the spectrum of common health concerns in postmenopausal women and their prevention and management.
Learning Objectives:
  1. Weigh the evidence for benefits versus harms when considering hormone replacement therapy for women with menopausal symptoms.
  2. Proactively screen and treat elderly women to prevent falls and fractures.
Faculty:
  1. Kelly Spratt, DO, FACC, FACP, Clinical Associate Professor of Medicine, University of PennsylvaniaPhiladelphia, PA (Bio)
CLOSE  X  
Fighting a Growing Epidemic: A Viral Hepatitis Update
Room: Ballroom A, Level 3
This session will provide up-to-date guidelines for screening and evaluating patients with HCV virus infection in the primary care setting. Current best evidence will be presented to guide initiation of antiviral therapy and treatment monitoring for HCV and HBV.
Learning Objectives:
  1. Assess updated guidelines for screening and evaluating patients for HCV in the primary care setting.
  2. Direct antiviral therapy for HCV and HBV using best available evidence.
  3. Monitor patients for antiviral treatment response and toxicities.
Faculty:
  1. Nancy Reau, MD, Associate Professor of Medicine, Medicine, University of Chicago Chicago, IL (Bio)
CLOSE  X  
Sinusitis in Children: Utilizing Guidelines in Clinical Practice
Room: Ballroom D, Level 3
Learning Objectives:
  1. Understand of the pathophysiology of acute bacterial sinusitis (ABS) in children.
  2. Understand the importance of clinical diagnosis of ABS and the limited role of diagnostic radiographic imaging in its management.
  3. Use antibiotics confidently and judiciously in the management of ABS.
  4. Provide information to patients and caregivers about the natural history of sinusitis, and the role of antibiotics and adjunctive measures in its management.
Faculty:
  1. Paul Krogstad, MD, Professor, Division of Pediatric Infectious Disease, Department of Pediatrics and Pharmacology, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
CLOSE  X  
The Overweight Child: Tips for the Primary Care Provider
Room: Ballroom D, Level 3
Learning Objectives:
  1. Employ evidence-based interventions, including community- and patient-based strategies, to prevent childhood obesity.
  2. Use provent therapies to treat obese pediatric patients.
Faculty:
  1. Wendy Slusser, MD, HS Clinical Professor, UCLA School of MedicineAnaheim, CA, UCLA Medical Director Fit for Health Program, Mattel Children's Hospital UCLALos Angeles, CA
CLOSE  X  
Lung Sounds: A Primer on Pulmonary Auscultation
Room: Hall C, Level 1
This primer on pulmonary auscultation will permit you to identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently, and link them to the scientific and literature validation that supports their clinical relevancy.
Learning Objectives:
  1. Recognize and identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently.
  2. Link literature validation and scientific basis to those sounds and extra-sounds which are clinically relevant.
  3. Establish a clinico-pathologic correlation for sounds and extra-sounds and murmurs.
Faculty:
  1. Salvatore Mangione, MD, Associate Professor of Medicine, Jefferson Medical CollegePhiladelphia, PA (Bio)
CLOSE  X  
An Algorithmic Approach to Diabetes Management: Combination Non-Insulin Therapy
Room: Ballroom A, Level 3
Improve your individualization of combination therapy for glycemic control in your diabetic patients that takes into account the entire patient support structure.
Learning Objectives:
  1. Differentiate among the drug classes’ pros and cons when considering combination non-insulin therapy for type 2 diabetes patients who are not at goal.
  2. Customize combination therapy by taking into account a patient’s support system, health care resources and desire/ability to take an active role in his/her diabetes care.
Faculty:
  1. Scott Joy, FACP, MD, Associate Professor of Medicine, The University of Colorado Health SystemDenver, CO (Bio)
CLOSE  X  
Kids Get Headaches Too! Evaluation and Treatment of the Pediatric Headache
Room: Ballroom D, Level 3
Learning Objectives:
  1. Diagnose the basic headaches in children using the most recent International Headache Society recommendations.
  2. Review the conventional headache therapies available for children.
  3. Understand the most recent literature on alternative therapies for headaches.
  4. Counsel patients on a variety of lifestyle changes to improve their headaches.
Faculty:
  1. Jason Lerner, MD, HS Assistant Clinical Professor, Department of Pediatrics, Neurology, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Office Asthma Care 2014
Room: Ballroom A, Level 3
Learning Objectives:
  1. Understand the 3 clinical criteria for establishing a diagnosis of asthma according to NIH asthma guidelines.
  2. Learn how to use an asthma questionnaire to classify asthma control/severity.
  3. Identify the differential diagnosis of uncontrolled asthma in children.
  4. Become familiar with strategies to assess inhaler technique and medication adherence.
Faculty:
  1. Sande Okelo, MD, PhD, Assistant Professor of Pediatrics, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
Management of COPD
Room: Hall C, Level 1
Learning Objectives:
  1. Counsel patients about aids to smoking cessation.
  2. Learn how to design a medical regimen for treating COPD of various degrees of severity.
  3. Identify the appropriate candidate for outpatient pulmonary rehabilitation.
  4. Consider the potential role of lung volume reduction in the treatment of emphysema.
Faculty:
  1. Christopher Fanta, MD, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA, Member, Pulmonary and Critical Care Division, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
Clinical Pearls in Pulmonary Medicine
Room: Hall C, Level 1
Learning Objectives:
  1. Consider the diagnostic possibilities causing hypercapnia.
  2. Understand the principles behind measurement of the diffusing capacity for carbon monoxide (DLCO).
  3. Recognize the utility of the flow-volume curve in assessing possible upper airway obstruction.
  4. Identify the "tree-in-bud" pattern on chest CT imaging and consider its differential diagnosis.
Faculty:
  1. Christopher Fanta, MD, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA, Member, Pulmonary and Critical Care Division, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
Pediatric Thyroid Dilemmas
Room: Ballroom A, Level 3
Learning Objectives:
  1. Understand the urgency of congenital hypothyroidism.
  2. Identify the presentation of acquired hypothyroidism in pediatrics.
  3. Discuss pitfalls in thyroid function tests.
  4. Identify preferred treatments for hyperthyroidism in pediatrics.
Faculty:
  1. Harvey Chiu, MD, Health Sciences Associate Clinical Professor, Division of Endocrinology, Department of Pediatrics, David Geffen School of Medicine at UCLALos Angeles, CA
CLOSE  X  
Concussion: Evaluation and Management of Sport-Related Injuries
Room: Ballroom A, Level 3
Learning Objectives:
  1. Learn the definition of concussion and the pathophysiology of traumatic brain injury.
  2. Identify who gets concussion.
  3. Assess and manage concussion and post-concussive symptoms.
  4. Implement the return-to-play protocol.
Faculty:
  1. Meeryo Choe, Clinical Instructor, Division of Pediatric Neurology, Mattel Children's Hospital UCLALos Angeles, CA
CLOSE  X  
Latent TB: Strategies for Detection and Management
Room: Hall C, Level 1
Learning Objectives:
  1. Learn how to differentiate LTBI from Tuberculosis disease.
  2. Discuss two different diagnostic tests and cost effectiveness of each.
  3. Define 4 categories that place an individual into the high risk category for progress to active TB disease.
  4. Discuss various drugs for chemoprophylaxis and the indications and side effects of each.
Faculty:
  1. Patrick Dowling, MD, Professor and Chair, Department of Family Medicine, David Geffen School of Medicine at UCLALos Angeles, CA (Bio)
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Mission Control: Medical Excellence
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Women’s Health Update: Clinical Pearls for Primary Care
9:45 AM-10:45 AM
Fighting a Growing Epidemic: A Viral Hepatitis Update
9:45 AM-10:25 AM
Sinusitis in Children: Utilizing Guidelines in Clinical Practice
 
10:25 AM-11:05 AM
The Overweight Child: Tips for the Primary Care Provider
 
10:45 AM-11:45 AM
Lung Sounds: A Primer on Pulmonary Auscultation
10:45 AM-11:45 AM
An Algorithmic Approach to Diabetes Management: Combination Non-Insulin Therapy
11:05 AM-11:45 AM
Kids Get Headaches Too! Evaluation and Treatment of the Pediatric Headache
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:25 PM
Management of COPD
1:45 PM-2:25 PM
Office Asthma Care 2014
 
2:25 PM-3:05 PM
Clinical Pearls in Pulmonary Medicine
2:25 PM-3:05 PM
Pediatric Thyroid Dilemmas
 
 
3:05 PM-3:45 PM
Latent TB: Strategies for Detection and Management
3:05 PM-3:45 PM
Concussion: Evaluation and Management of Sport-Related Injuries
 
 

Ticketed Events

For 2014, Pri-Med is implementing a new ticketing policy to give all attendees equal opportunity to attend the additional events within the conference. Distribution of all additional opportunity tickets will happen on-site on a first-come, first-served basis at the Ticket Booth. Please check-in early to ensure tickets are available for the additional opportunities you want to participate in. Limit 4 tickets per person.

Ticket Booth Hours
Wednesday, March 26: 6:30am–4:30pm
Thursday, March 27: 6:45am–2pm
Friday, March 28: 6:45am–2pm
Saturday, March 29: 6:45am–2pm

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Vaccines

Lunch Break

CME Educational Symposia

12:00 PM-1:30 PM

Rheumatoid Arthritis

Non-CME Presentation Theater

11:50 AM-12:35 PM

Cardiac Imaging

11:50 AM-12:35 PM

Lipids

11:50 AM-12:35 PM

Derm-Acne

11:50 AM-12:35 PM

Respiratory

11:50 AM-12:35 PM

Diabetes

11:50 AM-12:35 PM

Unbranded

Lunch 2

Non-CME Presentation Theater

12:55 PM-1:40 PM

obesity

12:55 PM-1:40 PM

Pancreatic Insufficiency

12:55 PM-1:40 PM

Session Information Coming Soon

Dinner

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Alzheimer's

8:55 AM-9:40 AM

Women's Health

Lunch Break

Non-CME Presentation Theater

11:50 AM-12:35 PM

Diabetes

11:50 AM-12:35 PM

AFIB/STROKE

11:50 AM-12:35 PM

Women's Health - NP/PA

11:50 AM-12:35 PM

Depression

11:50 AM-12:35 PM

COPD

11:50 AM-12:35 PM

Rheum/AS

Lunch

CME Educational Symposia

12:00 PM-1:30 PM

Diabetes

Lunch 2

Non-CME Presentation Theater

12:55 PM-1:40 PM

Low T

12:55 PM-1:40 PM

Diabetes

Dinner

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Men's Health

8:55 AM-9:40 AM

Dupuytrens Contracture

Lunch Break

Non-CME Presentation Theater

11:50 AM-12:35 PM

Gastro

11:50 AM-12:35 PM

Afib/Stroke

Lunch 2

CLOSE  X  
Pneumococcal Pneumonia and Invasive Disease in Adults: Help Protect Your Patients Aged 50+
Room: Theater 1
Faculty:
  1. Richard Stack
CLOSE  X  
RAPID - Rheumatoid Arthritis: A Primary Care Initiative for Improved Diagnosis and Outcomes
Room: Room 204, Level 2
Learning Objectives:
  1. Identify patients who have early RA by incorporating simple screening tests into daily practice
  2. Employ the squeeze test to assist with diagnosis of RA
  3. Order appropriate laboratory tests when RA is suspected
  4. Appropriately manage infections in patients taking DMARD therapy
  5. Assess and aggressively reduce CVD risk in RA patients
Faculty:
  1. Paul Doghramji, FAAFP , MD, Medical Director of Health Services, Ursinus CollegeCollegeville, PA, Family Physician, Collegeville Family PracticeCollegeville, PA (Bio)
  2. Orrin Troum, FACR , MD, Clinical Professor of Medicine, Division of Rheumatology, Keck School of Medicine, University of Southern CaliforniaLos Angeles, CA
  3. Lisa Diven, Director of the Women’s Intersport Network, Kansas City Sports Commission
The CME activity is supported by an educational grant from Supported by independent educational grants from Abbvie and Janssen Biotech .
CLOSE  X  
Evaluating and Determining Patients for Cardiac Radionuclide Imaging
Room: Theater 4
Faculty:
  1. David Wolinsky, MD, FACC, FASNC
CLOSE  X  
The Importance of Treating High Triglycerides
Room: Theater 1
Faculty:
  1. Pamela Kushner, MA, MD, FAAFP (Bio)
CLOSE  X  
Acne Treatment Guidelines and Patient Case Review
Room: Room 210A
Faculty:
  1. Andrew Krakowski, MD
CLOSE  X  
Therapeutic Advances in the Treatment of Small Airways And Asthma
Room: Theater 1
Faculty:
  1. Steven Weinstein, MD
CLOSE  X  
Advancing Paradigm Changes in Type 2 Diabetes Management
Room: Theater 3
Faculty:
  1. Stephen Brunton, FAAFP , MD
CLOSE  X  
Rethink HCV
Room: Theater 2
Faculty:
  1. Tram Tran, MD
CLOSE  X  
A Novel Treatment Option for Chronic Weight Management
Room: Theater 4
CLOSE  X  
Understanding the Data - Exocrine Pancreatic Insufficiency
Room: Theater 3
Faculty:
  1. Walter Coyle, FACG, MD, FACP
CLOSE  X  
TBD
CLOSE  X  
Emerging Trends in Alzheimer’s Disease Management: Namenda XR - a Treatment Option for Moderate to Severe Patients
Room: Theater 1
Faculty:
  1. Andrew Blumenfeld, MD
CLOSE  X  
What’s New in the Treatment of VMS
Room: Theater 2
Faculty:
  1. Michael Krychman, MD
CLOSE  X  
Improving Glycemic Control Through DPP-4 Inhibition: Treatment Considerations for Adult Patients With Type 2 Diabetes
Room: Theater 1
This program will present clinical data for a DPP-4 inhibitor used to improve glycemic control in adult patients with T2DM and its implications for regimen selection and individualization. Data on combination therapy with basal insulin will also be discussed.
Faculty:
  1. Farhad Zangeneh, MD, FACP, FACE
CLOSE  X  
Reducing the Risk of Stroke in Patients With Nonvalvular Atrial Fibrillation (NVAF)
Room: Theater 3
Faculty:
  1. J. Heywood, MD, FACC
CLOSE  X  
TBD
Room: Room 210A
CLOSE  X  
Discussion of a Treatment Option for Major Depressive Disorder
Room: Theater 2
Faculty:
  1. Gerald Maguire, MD, DFAPA
CLOSE  X  
COPD Care: Insights on Treatment Options An Open Gallery Event
Room: Room 208
Faculty:
  1. Stephen Brunton, FAAFP , MD
CLOSE  X  
Inflammatory Back Pain Recognition and Diagnosis
Room: Theater 4
Faculty:
  1. Sanjay Chabra, MD
CLOSE  X  
Managing the Risk of Hypoglycemia in the Patient with Type 2 DM
Room: Room 204, Level 2
Learning Objectives:
  1. Assess the results and explain the clinical implications of ACCORD, ADVANCE, and VADT studies.
  2. Identify risk factors that are associated with hypoglycemia in patient with type 2 diabetes and the importance of individualize glycemic targets.
  3. Describe special patient groups who are at an increase risk of adverse outcomes due to hypoglycemia.
  4. Outline current available antihyperglycemic agents that do not promote hypoglycemia.
  5. Device regimens that employ complimentary antihyperglycemic agents to optimize glycemic control while minimizing hypoglycemia risk in patients with type 2 diabetes.
Faculty:
  1. Frank Lavernia, MD, Founder and Director, North Broward Diabetes CenterPompano Beach, FL (Bio)
  2. James Gavin, III, MD, PhD, Clinical Professor of Medicine, Emory University School of MedicineAtlanta, GA, CEO & Chief Medical Officer, Healing Our Village, IncAtlanta, GA (Bio)
The CME activity is supported by an educational grant from Merck & Co., Inc..
CLOSE  X  
A Low-Volume Formulation for the Treatment of Hypogonadism
Room: Theater 4
Faculty:
  1. Mehran Movassaghi, MD
CLOSE  X  
The Role of Renal Glucose Excretion in Adults with Type 2 Diabetes
Room: Theater 2
Faculty:
  1. Neil Kaminsky
CLOSE  X  
Men’s Health Care Spotlight: The Management and Treatment of Erectile Dysfunction
Room: Theater 3
Faculty:
  1. Josh Randall
CLOSE  X  
Dupuytren's Contracture in Adults with a Palpable Cord: Clinical Overview and Treatment Options
Room: Theater 2
Faculty:
  1. Michael Rubinstein, MD
CLOSE  X  
Hepatic Encephalopathy: A Clinical Dialogue on a Chronic Complication of Cirrhosis
Room: Theater 4
Hepatic encephalopathy (HE) is a chronic complication of cirrhosis that causes a variety of mental and physical symptoms. HE can occur in up to 45% of patients with cirrhosis. It is a debilitating condition marked by a cycle of remission followed by recurrence that is difficult to break. This program explores a twice-daily therapy for reducing the risk of HE recurrence.
Faculty:
  1. Sammy Saab, MD , MPH , AGAF
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Room: Theater 3
Faculty:
  1. Randy Lieberman, MD

Accreditation

Earn up to 27 AMA PRA Category 1 Credits™ or 27 AANP contact hours of continuing education.

Primary Care Updates—Track One
March 26, 2014
Credits Type Accreditation Statement Designation Statement
8 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8 AAFP This Live activity, West Primary Care Updates – Track 1, with a beginning date of 3/26/2014, has been reviewed and is acceptable for up to 8.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 8 contact hours of continuing education (which includes 4.000 hours of pharmacology).
Primary Care Updates—Track Two
March 26, 2014
Credits Type Accreditation Statement Designation Statement
7.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
7.75 AAFP This Live activity, West Primary Care Updates – Track 2, with a beginning date of 3/26/2014, has been reviewed and is acceptable for up to 7.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
7.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 7.75 contact hours of continuing education (which includes 3.875 hours of pharmacology).
Primary Care Updates—Track Three
March 26, 2014
Credits Type Accreditation Statement Designation Statement
8 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8 AAFP This Live activity, West Primary Care Updates – Track 3, with a beginning date of 3/26/2014, has been reviewed and is acceptable for up to 8.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 8 contact hours of continuing education (which includes 4.000 hours of pharmacology).
Annual Conference
March 27—29, 2014
Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ This Live activity, Pri-Med West - Annual Conference, with a beginning date of 03/27/2014, has been reviewed and is acceptable for up to 19.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. pmiCME designates this live educational activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
19 AAFP This live activity, West Annual Conference, with a begin date of 3/27/2014, has been reviewed and is acceptable for up to 19 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
19 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 19 contact hours of continuing education (which includes 9.500 hours of pharmacology).

Keynote Speakers

Michael Dansinger, MD (Read Bio)

Tufts Medical Center, Boston, MA

Presenting on:

Linda Hill, MD (Read Bio)

Clinical Professor, Department of Family and Preventive Medicine
University of California, San Diego, San Diego, CA
Associate Professor of Health Promotion, Graduate School of Public Health
San Diego State, San Diego, CA

Presenting on:

Story Musgrave, MD, MS (Read Bio)

NASA,
Applied Minds Inc.,
Art Center College of Design, Pasadena, CA

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Thursday, March 27 8:30am–2:30pm
Friday, March 28 8:30am–2:30pm
Saturday, March 29 8:30am–2pm

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

Pri-Med Mobile App Available Now!

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.

Exhibitor List

Company Name Booth Number
A Fashion Hayvin, Inc. 364
AbbVie 149
Aegis Treatment Centers 950
Akeso Health Sciences 844
Alzheimers Association 440
Amazing Charts 413
American Diabetes Association 455
American Herbal Labs & Nano Vita Water 729
Army Medical Recruiting 756
AstraZeneca/BMS Alliance 749
Auxilium Pharmaceuticals, Inc. 442
Avmacol 617
Bionix Medical Technologies 121
Boehringer Ingelheim Pharmaceuticals, Inc. 513
Boston Heart Diagnostics 826
California Academy of Physician Asst 748
Calmoseptine, Inc. 354
Carlson Laboratories 535
Central Drugs Compounding Pharmacy 668
Concentra 860
CryoProbe 116
Cynosure Inc 835
Dannon Company Inc 463
Department of Veterans Affairs 816
diaDexus, Inc. 857
Doximity 454
Elsevier Medical Books 341
Exalenz Bioscience Ltd. 560
Forest Pharmaceuticals, Inc. 141
Galderma Laboratories LP 564
Gensco Laboratories 842
Grifols USA, LLC. 351
HemoCue America 615
HOLOGIC, Inc. 350
Hyperion Medical 344
Infinite Therapeutics 361
Janssen Pharmaceuticals, Inc 561
Kareo 827
Laclede Inc. 212
Lippincott Williams & Wilkins 232
Magine Events 613
Mederi Therapeutics, Inc 340
Merck 447
Micro Direct, Inc. 620
Mobius MGMT Group, LLC 863
Monthly Prescribing Reference 845
Navajo Jewelry & Crafts 261
New Balance Athletic Shoes 624
Novartis Pharmaceuticals 441
Novo Nordisk Inc. 541
Nutramax Laboratories Consumer Care, Inc. 726
Office Ally 356
Orasure Technologies, Inc. 657
Otto Trading, Inc. 265
Pfizer Inc. 948
Pri-Med Recharge Lounge 429
Qiagen, Inc. 853
Revive Pharmaceuticals 823
Salix Pharmaceuticals, Inc. 720
Sanofi Pasteur Inc. 752
Seca 656
Shader Productions 264
Sigma Tau Pharmaceuticals 840
Southwest Medical Books 649
Summit Doppler Systems 648
Takeda Pharmaceuticals U.S.A., Inc. 213
TelMedIQ 761
The Gideons International 365
UC Irvine, The Paul Merage School of Business 768
UltraScope 623
Vital Nutrients 255
Xenna Corp 743
Company Name Booth Number
AbbVie 112
Accessory Mania 368
Aerolase 741
Altamed Health Services 652
Amarin Pharma, Inc. 713
American College of Physicians 820
American Express 369
Argus Medical Management 856
AspirinWorks by Corgenix 832
Atherotech 712
Auxilium Pharmaceuticals, Inc. 763
Biofilm, Inc. 342
Bio-Oil 462
Boiron 632
Bridges to Recovery 728
California Walnut Board & Commission 525
Care More 833
Cell Science Systems/ALCAT 251
CME Corner / MCM Education 549
ConnectRx 654
CryoSurgery, Inc 120
Daiichi Sankyo, Inc. 328
Department of State- Office of Medical Services 864
Dermalogix Partners Inc 834
Diva International Inc. 122
Eisai, Inc. 421
e-MDs 862
FIGS Medical Apparel 357
FRONTRUNNERS BOARD REVIEW 735
Genova Diagnostics, Inc 569
Gilead Sciences 633
HAE: Learn About It, Talk About It 556
Hemosure 723
HydraFacial MD - Edge Systems LLC 621
i-Lipo / Chromogenex 348
International Tree Nut Council Nutrition Research & Education Foundation 533
Kaiser Permanente 554
LA County Department of Health Services 828
LiLa Enterprise 461
Los Angeles County Sheriff's Department 469
Maico Diagnostics 117
Medical Device Division of OAPI, Inc. 226
Merrill Lynch 755
Minute Clinic 456
Molina Medical Group 553
Mylan Inc. 343
Neilmed Pharmaceuticals, Inc. 214
Newman Medical 669
Noven Pharmaceuticals Inc 841
Nu-Skin 521
OA Systems, Inc. 627
On the Avenue Marketing 727
Otto Trading, Inc. 263
Pfizer Inc. 653
Planned Parenthood 865
Pri-Med Solutions Center 313
Renua Medical 868
Safe Harbor Treatment Center 464
Sanofi 241
Scarf King 260
Sekisui Diagnostics 230
Shire 717
Singulex Inc. 355
Spondylitis Association of America 651
Take Care Health Systems 716
Tec Laboratories, Inc. 750
Teva Respiratory 113
Tutto/Mascot Metropolitan Inc 268
Ultimate Creations 360
US HealthWorks 861
WynnPharm Inc. 349
Zanfel Laboratories, Inc. 256
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Anaheim Convention Center
800 W Katella Ave
Anaheim, CA 92802-3496
(714) 765-8950

Hotel Accommodations

Good Health Begins Here

Company
Exhibitors
Support
Terms
Tel: (877) 477-4633